Clinical Laserthermia Systems ABOMXSTO: CLS_B

Clinical Laserthermia Systems AB: Quarterly Trading Report 2025 Q3

Oct 3, 2025 at 11:04 AM EDT · Issued by Clinical Laserthermia Systems AB

On 6ix: 6ix.com/news/clinical-laserthermia-systems-ab-quarterly-trading-report-2025-q3

Nordic ListingsIssuer Report

Clinical Laserthermia Systems AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=b13499515a737d1b0e7a213ca7efa7234&lang=en&src=omxlink

Clinical Laserthermia Systems AB on 6ix

Earlier from Clinical Laserthermia Systems

CLS Raises SEK 20.9 Mln Through Full Subscription Of WarrantsSep 30, 2025
CLS_B: Record Q2 sales and improved margins drive narrowed losses and strong growth outlookAug 22, 2025
CLS_B: Revenue up 43% and operating loss halved as CLS accelerates neurosurgery commercializationMay 16, 2025
CLS_B: CLS doubled sales, improved margins, and refocused on neurosurgery for high-margin growthFeb 21, 2025
CLS_B: CLS accelerates neurosurgery growth, narrows losses, and targets profitability by 2026Oct 31, 2024

Later from Clinical Laserthermia Systems

CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive resultsOct 7, 2025
Clinical Laserthermia Systems Q3 Revenue SEK 2.8 MlnNov 14, 2025
CLS Initiates Recruitment Process For Permanent Chief Financial OfficerDec 12, 2025
Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026Feb 20
CLS Receives Order Worth SEK 23 Mln For Prism BusinessMay 11

All Clinical Laserthermia Systems news releases

Follow Clinical Laserthermia Systems into a list and get an email when it puts out news.

Follow Clinical Laserthermia Systems